2 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Active not recruiting 2, Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
Follow Ocugen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD OCU410 - Dry Age-related Macular Degeneration | Phase 3 | Recruiting | Ocugen | 237 | 2026-08-11 | 2026-08-19 |
| A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa Sub-Retinal Administration of OCU400-301 - Retinitis Pigmentosa | Phase 3 | Active not recruiting | Ocugen | 140 | 2024-06-18 | 2026-07-31 |
| A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease OCU410ST - Stargardt Disease | Phase 2 / Phase 3 | Active not recruiting | Ocugen | 51 | 2023-08-25 | 2026-07-31 |
| Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults BBV152 - COVID-19 | Phase 2 / Phase 3 | Unknown | Ocugen | 400 | 2022-02-20 | 2023-03-27 |
| Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease Brimonidine Tartrate, Placebos - Graft Versus Host Disease, Ocular Surface Disease | Phase 3 | Terminated | Ocugen | 59 | 2018-12-23 | 2022-07-06 |
| Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) Brimonidine Tartrate, Placebos - Dry Eye | Phase 3 | Completed | Ocugen | 252 | 2018-12-03 | 2022-07-18 |
COVID-19 (1) · Dry Eye Syndromes (1) · Graft vs Host Disease (1) · Retinitis Pigmentosa (1) · Stargardt Disease (1)
Brimonidine Tartrate (2) · BBV152 COVID-19 vaccine (1)
United States (6) · Canada (1)
Mohamed Genead, MD (3) · Jennifer Henrick, RN, MS (2) · Huma Qamar, MD, MPH, CMI (1) · Jennifer Henrick (1)